K. Stephans

Phase I study of recombinant human CD40 ligand in cancer patients.

J. Gribben, J. Dutcher, J. Anderson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes

W. Hahn, M. Loda, K. Anderson, 2004, Clinical Cancer Research.

Advances in Brief Equivalent Induction of Telomerase-specific Cytotoxic T Lymphocytes from Tumor-bearing Patients and Healthy Individuals 1

W. Hahn, K. Anderson, M. Kuroda, 2001 .

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.

W. Hahn, K. Anderson, M. Kuroda, 2001, Cancer research.

Topology based radiomic feature derived from persistent homology predicts survival in non-small cell lung cancer patients treated with SBRT

G. Videtic, M. Kattan, R. Wadhwa, 2022, medRxiv.

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.

J. Gribben, J. Friedberg, D. Neuberg, 2004, Leukemia research.

Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.

J. Gribben, J. Ritz, D. Fisher, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I S tudy o f R ecombinant H uman C D40 L igand i n Cancer P atients

J. Gribben, J. Dutcher, Jeanne E. Anderson, 2001 .

Fludarabine and Alemtuzumab Versus Fludarabine and Rituximab in the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia: Results from a Phase II Study.

J. Gribben, K. Stephans, B. Marshal, 2005 .

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

J. Gribben, D. Neuberg, L. Sequist, 2005, Blood.